CA$
29. 11
+1.04
+3.705%
CA$
385.73B Market Cap
22.58 P/E Ratio
16.17% Div Yield
485 Volume
7.13 Eps
CA$ 28.07
Previous Close Want to track NVS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Novartis AG (NVS) Statistics
Valuation metrics
Market Cap 385.73B
Enterprise value 102.11B
Trailing P/E (ttm) 18.81
Forward P/E -
PEG ratio -1.91
Price/Sales (ttm) 7.01
Price/Book (mrq) 1.25
Enterprise Value/Revenue 1.34
Enterprise Value/EBITDA 3.15
Overview
Shares outstanding 1.91B
Float 1.84B
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 757
Average volume (90 days) 10.33K
Price summary
52-Week low 21.67
52-Week high 31
Beta 0.57
50-Day moving average 23.92
200-Day moving average 22.77
Financials
Fiscal year
Fiscal year ends 31 Dec 2024
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.25%
Operating margin 0.37%
Operational effectiveness
Return on assets 0.12%
Return on equity 0.32%
Income Statement
Revenue (ttm) 75.91B
Revenue per share (ttm) 27.9
Quarterly revenue growth (yoy) 0.15%
Gross profit (ttm) 57.91B
EBITDA 22.4B
Net income to common (ttm) 18.78B
Diluted EPS (ttm) 1.44
Quarterly earnings growth (yoy) 0.24%
Balance Sheet
Total cash (mrq) 9.26B
Total cash per share (mrq) 3.48
Total debt (mrq) 44.89B
Total Debt/Equity (mrq) 77.61
Current ratio (mrq) 0.82%
Book value per share (mrq) 21.69
Cash Flow
Cash flow statement 28.59B
Levered free cash flow (LFCF) 20.2B
